NCT06136377View on ClinicalTrials.gov

Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Patients With Metastatic Castration-resistant Prostate Cancer

Interventions

RADIATION

177Lu-PSMA-617 PET scan

Patients then begin their first course of treatment an average of 2 months after the 68Ga-PSMA-11 PET scan, with IVR usually divided into a total of 6 courses. During the first course of treatment, patients undergo an initial SPECT scan 5h (±1h) post-injection, and return to the nuclear medicine department for three further SPECT scans, at 24h, 4 days and 8 days post-injection.

All Listed Sponsors

lead

Centre Georges Francois Leclerc

OTHER